EPS Drops at the Regional Banks company during the fiscal fourth quarter of 2022

For the fiscal fourth quarter of 2022 Quaint Oak Bancorp Inc net profit per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year prior and profit plummeted by -55.19 % from $1.22 per share from the previous financial reporting period.

Revenues sunk by -6.343 % to $8.80 millions from $9.40 millions in the similar financial reporting period a year prior and sequentially Revenues fell by -26.514 % from $11.98 millions.

Quaint Oak Bancorp Inc stock quotes, charts, profile

Quaint Oak Bancorp Inc Revenue advance Rates

The company announced rather significant decline in their top-line, during the fourth quarter of 2022 earnings season

In the fourth quarter of 2022 earnings season Computer Hardware company announced soft top and bottom-line, where reached break-even and revenue by -15.427 % year on year. Revenue were to $5.17 millions relative to $6.11 millions eps at $0.00 in contrast to $0.09 in the fiscal three months ending December 31 2021.

Socket Mobile Inc Suppliers

Socket Mobile Inc improvement Rates, Profitability, PE

Better Therapeutics Inc announced operating deficit of $-8.322 millions, in the October to December 31 2022

After the large companies in the Medical Equipment & Supplies sector, a number of lesser known businesses are reporting the results. BTTX told it has booked operating deficit of $-8.322 millions, for the fourth quarter of 2022.

Better Therapeutics Inc Competitors, Market Share

Better Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

For the fiscal period ending December 31 2022 Aptevo Therapeutics Inc decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and earnings per share improved from $-1.50 per share from the prior reporting season.

Revenues remained unscathed to $0.00 millions from $3.67 millions in the comparable reporting season a year prior and sequentially Revenues surged from $0.00 millions.

Aptevo Therapeutics Inc stock quotes, charts, profile

Aptevo Therapeutics Inc Revenue rise Rates

Directing the awareness to the fourth quarter of 2022 the Construction Services company recorded a shortfall per stock at $-0.75 per share, relative to the results of $7.33 per share a year ago quarter, In the preceding quarter the Stratus Properties Inc realized $-0.29 per share.

Stratus Properties Inc stock quotes, charts, profile

Stratus Properties Inc growth Rates, Profitability, PE

Again Positive Income at the Aei Income And Growth Fund Xxi Limited Partnership amid the fourth quarter of 2022 earnings season

For the fourth quarter of 2022 earnings season NONE income turned positive of $0.01 per share compare to $-0.14 a year before and earnings per share dropped by -99.63 % from $1.64 per share from the prior reporting season.

Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the similar reporting season a year before and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.

Aei Income And Growth Fund Xxi Limited Partnership Competitors, Market Share

Aei Income And Growth Fund Xxi Limited Partnership Suppliers

Deficit higher than a year ago at the Creative Media And Community Trust Corporation amid the fiscal interval closing December 31 2022

For the fiscal interval closing December 31 2022 CMCT Diminishing Returns have extended of $-0.39 per share compare to $-0.38 a year ago and EPS improved from $-0.50 per share from the prior reporting period.

Revenue grew softly by 2.957 % to $25.87 millions from $25.13 millions in the same reporting period a year ago and sequentially Revenues increased by 4.084 % from $24.85 millions.

Creative Media And Community Trust Corporation stock quotes, charts, profile

Creative Media And Community Trust Corporation Suppliers

A deficit of $-0.04 per Share at AWH amid the October to December 31 2022 period

For the October to December 31 2022 period company lost money of $-0.04 per share compare to $-0.08 a year prior and from $-0.04 per share from the preceding reporting season.

Revenues rose admirably by 16.316 % to $2.15 millions from $1.85 millions in the similar reporting season a year prior and sequentially Revenues grew by 3.909 % from $2.07 millions.

Aspira Women S Health Inc Suppliers

Aspira Women S Health Inc elevation Rates, Profitability, PE

Revenues receded by -6.343 %, at QNTO amid the financial fourth quarter of 2022

For the fiscal fourth quarter of 2022 QNTO earnings per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year before and profit plummeted by -55.19 % from $1.22 per share from the preceding quarter.

Revenues decreased by -6.343 % to $8.80 millions from $9.40 millions in the corresponding quarter a year before and sequentially Revenues fell by -26.514 % from $11.98 millions.

Quaint Oak Bancorp Inc Competitors, Market Share

Quaint Oak Bancorp Inc Revenue growth Rates

EPS Drops due to Weak Sales at in the fourth quarter of 2022 earnings season

In the most recent fiscal period SCKT declared soft top and bottom-line, where reached zero gain and revenue by -15.427 % year on year. Revenue were to $5.17 millions in contrast to $6.11 millions eps at $0.00 compared to $0.09 in fourth quarter of 2021.

Socket Mobile Inc Competitors, Market Share

Socket Mobile Inc Income Statement, Balance sheets, Cash Flow Statement

In the financial fourth quarter of 2022 operating deficit reflected enhancement to $-30.002921 millions, at the Better Therapeutics Inc

Following the large companies in the Medical Equipment & Supplies industry, a number of smaller businesses are impending with the numbers. BTTX revealed it has announced operating deficit of $-8.322 millions, for the fourth quarter of 2022.

Better Therapeutics Inc stock quotes, charts, profile

Better Therapeutics Inc Revenue improvement Rates

For the most recent fiscal period APVO decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and earnings per share improved from $-1.50 per share from the preceding reporting season.

Revenues remained unchanged to $0.00 millions from $3.67 millions in the similar reporting season a year prior and sequentially Revenues surged from $0.00 millions.

Aptevo Therapeutics Inc Customers

Aptevo Therapeutics Inc Suppliers

Considering the financial interval ending December 31 2022 CADL Diminishing Returns have widen at $-0.15 per share, relative to the recent numbers of $1.54 per share a year before financial reporting period, In the previous financial reporting period CADL realized $-0.30 per share.

Candel Therapeutics Inc Suppliers

Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement